87 related articles for article (PubMed ID: 17348452)
1. Relationship between chromosome 18q status and colorectal cancer prognosis: a prospective, blinded analysis of 280 patients.
Popat S; Zhao D; Chen Z; Pan H; Shao Y; Chandler I; Houlston RS
Anticancer Res; 2007; 27(1B):627-33. PubMed ID: 17348452
[TBL] [Abstract][Full Text] [Related]
2. Association between recurrence of sporadic colorectal cancer, high level of microsatellite instability, and loss of heterozygosity at chromosome 18q.
Sarli L; Bottarelli L; Bader G; Iusco D; Pizzi S; Costi R; D'Adda T; Bertolani M; Roncoroni L; Bordi C
Dis Colon Rectum; 2004 Sep; 47(9):1467-82. PubMed ID: 15486743
[TBL] [Abstract][Full Text] [Related]
3. Allelic loss of chromosome 18q and prognosis in colorectal cancer.
Jen J; Kim H; Piantadosi S; Liu ZF; Levitt RC; Sistonen P; Kinzler KW; Vogelstein B; Hamilton SR
N Engl J Med; 1994 Jul; 331(4):213-21. PubMed ID: 8015568
[TBL] [Abstract][Full Text] [Related]
4. Allelic status of chromosomes 17p, 18q, 22q [corrected] 3p and their clinical usefulness in colorectal cancer.
Fujita S; Baba H; Yamamoto S; Akasu T; Moriya Y; Sugano K
Anticancer Res; 2006; 26(4B):2833-40. PubMed ID: 16886602
[TBL] [Abstract][Full Text] [Related]
5. SMAD4 as a prognostic marker in colorectal cancer.
Alazzouzi H; Alhopuro P; Salovaara R; Sammalkorpi H; Järvinen H; Mecklin JP; Hemminki A; Schwartz S; Aaltonen LA; Arango D
Clin Cancer Res; 2005 Apr; 11(7):2606-11. PubMed ID: 15814640
[TBL] [Abstract][Full Text] [Related]
6. A systematic review and meta-analysis of the relationship between chromosome 18q genotype, DCC status and colorectal cancer prognosis.
Popat S; Houlston RS
Eur J Cancer; 2005 Sep; 41(14):2060-70. PubMed ID: 16125380
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of 18q LOH in sporadic colorectal carcinoma.
Pilozzi E; Ferri M; Onelli MR; Mercantini P; Corigliano N; Duranti E; Dionisi L; Felicioni F; Virgilio E; Ziparo V; Ruco L
Am Surg; 2011 Jan; 77(1):38-43. PubMed ID: 21396303
[TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor gene polymorphisms associated with prognosis for patients with colorectal cancer.
Kim JG; Chae YS; Sohn SK; Cho YY; Moon JH; Park JY; Jeon SW; Lee IT; Choi GS; Jun SH
Clin Cancer Res; 2008 Jan; 14(1):62-6. PubMed ID: 18172253
[TBL] [Abstract][Full Text] [Related]
9. Allelic imbalances of chromosomes 8p and 18q and their roles in distant relapse of early stage, node-negative breast cancer.
Morikawa A; Williams TY; Dirix L; Colpaert C; Goodman M; Lyles RH; Zhong D; Zhou W
Breast Cancer Res; 2005; 7(6):R1051-7. PubMed ID: 16457686
[TBL] [Abstract][Full Text] [Related]
10. Mutation status of K-ras, p53 and allelic losses at 9p and 18q are not prognostic markers in patients with pancreatic cancer.
Salek C; Minarikova P; Benesova L; Nosek V; Strnad R; Zavoral M; Minarik M
Anticancer Res; 2009 May; 29(5):1803-10. PubMed ID: 19443408
[TBL] [Abstract][Full Text] [Related]
11. Genome-wide allelotyping of 104 Finnish colorectal cancers reveals an excess of allelic imbalance in chromosome 20q in familial cases.
Laiho P; Hienonen T; Karhu A; Lipton L; Aalto Y; Thomas HJ; Birkenkamp-Demtroder K; Hodgson S; Salovaara R; Mecklin JP; Järvinen H; Knuutila S; Halford S; Ørntoft TF; Tomlinson I; Launonen V; Houlston R; Aaltonen LA
Oncogene; 2003 Apr; 22(14):2206-14. PubMed ID: 12687022
[TBL] [Abstract][Full Text] [Related]
12. Allelic loss on chromosome 18q as a prognostic marker in stage II colorectal cancer.
Martínez-López E; Abad A; Font A; Monzó M; Ojanguren I; Pifarré A; Sánchez JJ; Martín C; Rosell R
Gastroenterology; 1998 Jun; 114(6):1180-7. PubMed ID: 9609754
[TBL] [Abstract][Full Text] [Related]
13. E-selectin gene S128R polymorphism is associated with poor prognosis in patients with stage II or III colorectal cancer.
Hebbar M; Adenis A; Révillion F; Duhamel A; Romano O; Truant S; Libersa C; Giraud C; Triboulet JP; Pruvot FR; Peyrat JP
Eur J Cancer; 2009 Jul; 45(10):1871-6. PubMed ID: 19361981
[TBL] [Abstract][Full Text] [Related]
14. Interleukin promoter polymorphisms and prognosis in colorectal cancer.
Wilkening S; Tavelin B; Canzian F; Enquist K; Palmqvist R; Altieri A; Hallmans G; Hemminki K; Lenner P; Försti A
Carcinogenesis; 2008 Jun; 29(6):1202-6. PubMed ID: 18448485
[TBL] [Abstract][Full Text] [Related]
15. Chromosome 18q deletion and Smad4 protein inactivation correlate with liver metastasis: A study matched for T- and N- classification.
Tanaka T; Watanabe T; Kazama Y; Tanaka J; Kanazawa T; Kazama S; Nagawa H
Br J Cancer; 2006 Dec; 95(11):1562-7. PubMed ID: 17088901
[TBL] [Abstract][Full Text] [Related]
16. Evidence that genetic instability occurs at an early stage of colorectal tumorigenesis.
Shih IM; Zhou W; Goodman SN; Lengauer C; Kinzler KW; Vogelstein B
Cancer Res; 2001 Feb; 61(3):818-22. PubMed ID: 11221861
[TBL] [Abstract][Full Text] [Related]
17. MGMT germline polymorphism is associated with somatic MGMT promoter methylation and gene silencing in colorectal cancer.
Ogino S; Hazra A; Tranah GJ; Kirkner GJ; Kawasaki T; Nosho K; Ohnishi M; Suemoto Y; Meyerhardt JA; Hunter DJ; Fuchs CS
Carcinogenesis; 2007 Sep; 28(9):1985-90. PubMed ID: 17621591
[TBL] [Abstract][Full Text] [Related]
18. Microsatellite analysis of allelic imbalance in tumour and blood from patients with prostate cancer.
Schwarzenbach H; Chun FK; Müller I; Seidel C; Urban K; Erbersdobler A; Huland H; Pantel K; Friedrich MG
BJU Int; 2008 Jul; 102(2):253-8. PubMed ID: 18336598
[TBL] [Abstract][Full Text] [Related]
19. [Pharmacogenetic studies on the prediction of efficacy and toxicity of fluoropyrimidine-based adjuvant therapy in colorectal cancer].
Kralovánszky J; Adleff V; Hitre E; Pap E; Réti A; Komlósi V; Budai B
Magy Onkol; 2007; 51(2):113-25. PubMed ID: 17660867
[TBL] [Abstract][Full Text] [Related]
20. Allelic imbalance is not restricted to numerically abnormal chromosomes in epithelial ovarian tumours.
Evans MF; Herrington CS
J Pathol; 2001 Nov; 195(4):443-50. PubMed ID: 11745676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
